InvestmentJul 13, 2026, 05:11 PM
Beneficient Closes $7.44M GP Primary Capital Transaction
AI Summary
Beneficient announced the closing of a $7.44 million GP primary capital transaction with Quartus AI Fund II LP, an AI-focused investment fund. In exchange, Beneficient issued 744,455 shares of Series B-11 Resettable Convertible Preferred Stock, convertible into Class A Common Stock at an initial price of $3.6514 per share. This transaction is expected to increase the collateral for the company's ExAlt loan portfolio and add approximately $7.44 million to tangible book value attributable to stockholders, contributing to a fiscal year-to-date total of $17.2 million from such transactions.
Key Highlights
- Closed $7.44 million GP primary capital transaction with Quartus AI Fund II LP.
- Issued 744,455 shares of Series B-11 Resettable Convertible Preferred Stock.
- Initial conversion price for Series B-11 Preferred Stock is $3.6514 per share.
- Maximum of 4,077,642 Class A Common Stock shares may be issued upon conversion.
- Transaction increases collateral for ExAlt loan portfolio by approximately $7.44 million.
- Adds approximately $7.44 million to tangible book value attributable to stockholders.
- Fiscal year-to-date GP primary capital transactions contributed $17.2 million to tangible book value.
Price Impact
More from BENF